Total: £ 56.28
Published Date: 2026-02-03 | Pages: 151 | Tables: 144 | Medical Care
The global Point of Care Blood Testing Product market was valued at US$ 20370 million in 2025 and is anticipated to reach US$ 32920 million by 2032, at a CAGR of 7.2% from 2026 to 2032.
Point-of-Care (POC) blood testing products refer to diagnostic tools and devices that allow medical professionals to conduct rapid blood tests at the patient's location, such as a clinic, hospital bedside, or even at home. These products provide immediate results, facilitating quicker medical decisions and improving patient outcomes by reducing the time needed for diagnosis. Common POC blood testing products include portable glucose meters, cholesterol testers, and devices for measuring blood gases and electrolytes.
The North American market for Point of Care Blood Testing Product is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Point of Care Blood Testing Product is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Point of Care Blood Testing Product in Hospital & Clinic is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Point of Care Blood Testing Product include Roche, Abbott, LifeScan, Siemens Healthineers, Danaher, Ascensia, BioMerieux, ARKRAY, Bio-Rad Laboratories, Nova Biomedical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Point of Care Blood Testing Product market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Point of Care Blood Testing Product. The Point of Care Blood Testing Product market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Point of Care Blood Testing Product market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Point of Care Blood Testing Product manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Roche
Abbott
LifeScan
Siemens Healthineers
Danaher
Ascensia
BioMerieux
ARKRAY
Bio-Rad Laboratories
Nova Biomedical
QuidelOrtho
Accriva
OraSure Technologies
Helena Laboratories
Phamatech
Chembio Diagnostics
Trinity Biotech
Wuhan Easy Diagnosis
Intec PRODUCT
Sinocare
Wondfo
Getein Biotech
Segment by Type
Consumables
Devices
Segment by Application
Hospital & Clinic
Laboratory
Household
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Point of Care Blood Testing Product companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care Blood Testing Product Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Consumables
1.2.3 Devices
1.3 Market by Application
1.3.1 Global Point of Care Blood Testing Product Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital & Clinic
1.3.3 Laboratory
1.3.4 Household
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point of Care Blood Testing Product Market Perspective (2021–2032)
2.2 Global Point of Care Blood Testing Product Growth Trends by Region
2.2.1 Global Point of Care Blood Testing Product Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Point of Care Blood Testing Product Historic Market Size by Region (2021–2026)
2.2.3 Point of Care Blood Testing Product Forecasted Market Size by Region (2027–2032)
2.3 Point of Care Blood Testing Product Market Dynamics
2.3.1 Point of Care Blood Testing Product Industry Trends
2.3.2 Point of Care Blood Testing Product Market Drivers
2.3.3 Point of Care Blood Testing Product Market Challenges
2.3.4 Point of Care Blood Testing Product Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care Blood Testing Product Players by Revenue
3.1.1 Global Top Point of Care Blood Testing Product Players by Revenue (2021–2026)
3.1.2 Global Point of Care Blood Testing Product Revenue Market Share by Players (2021–2026)
3.2 Global Top Point of Care Blood Testing Product Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Point of Care Blood Testing Product Revenue
3.4 Global Point of Care Blood Testing Product Market Concentration Ratio
3.4.1 Global Point of Care Blood Testing Product Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care Blood Testing Product Revenue in 2025
3.5 Global Key Players of Point of Care Blood Testing Product Head Offices and Areas Served
3.6 Global Key Players of Point of Care Blood Testing Product, Products and Applications
3.7 Global Key Players of Point of Care Blood Testing Product, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Point of Care Blood Testing Product Breakdown Data by Type
4.1 Global Point of Care Blood Testing Product Historic Market Size by Type (2021–2026)
4.2 Global Point of Care Blood Testing Product Forecasted Market Size by Type (2027–2032)
5 Point of Care Blood Testing Product Breakdown Data by Application
5.1 Global Point of Care Blood Testing Product Historic Market Size by Application (2021–2026)
5.2 Global Point of Care Blood Testing Product Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Point of Care Blood Testing Product Market Size (2021–2032)
6.2 North America Point of Care Blood Testing Product Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Point of Care Blood Testing Product Market Size by Country (2021–2026)
6.4 North America Point of Care Blood Testing Product Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point of Care Blood Testing Product Market Size (2021–2032)
7.2 Europe Point of Care Blood Testing Product Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Point of Care Blood Testing Product Market Size by Country (2021–2026)
7.4 Europe Point of Care Blood Testing Product Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Point of Care Blood Testing Product Market Size (2021–2032)
8.2 Asia-Pacific Point of Care Blood Testing Product Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Point of Care Blood Testing Product Market Size by Region (2021–2026)
8.4 Asia-Pacific Point of Care Blood Testing Product Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Point of Care Blood Testing Product Market Size (2021–2032)
9.2 Latin America Point of Care Blood Testing Product Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Point of Care Blood Testing Product Market Size by Country (2021–2026)
9.4 Latin America Point of Care Blood Testing Product Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care Blood Testing Product Market Size (2021–2032)
10.2 Middle East & Africa Point of Care Blood Testing Product Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Point of Care Blood Testing Product Market Size by Country (2021–2026)
10.4 Middle East & Africa Point of Care Blood Testing Product Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Point of Care Blood Testing Product Introduction
11.1.4 Roche Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Point of Care Blood Testing Product Introduction
11.2.4 Abbott Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.2.5 Abbott Recent Development
11.3 LifeScan
11.3.1 LifeScan Company Details
11.3.2 LifeScan Business Overview
11.3.3 LifeScan Point of Care Blood Testing Product Introduction
11.3.4 LifeScan Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.3.5 LifeScan Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Point of Care Blood Testing Product Introduction
11.4.4 Siemens Healthineers Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.4.5 Siemens Healthineers Recent Development
11.5 Danaher
11.5.1 Danaher Company Details
11.5.2 Danaher Business Overview
11.5.3 Danaher Point of Care Blood Testing Product Introduction
11.5.4 Danaher Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.5.5 Danaher Recent Development
11.6 Ascensia
11.6.1 Ascensia Company Details
11.6.2 Ascensia Business Overview
11.6.3 Ascensia Point of Care Blood Testing Product Introduction
11.6.4 Ascensia Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.6.5 Ascensia Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Details
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux Point of Care Blood Testing Product Introduction
11.7.4 BioMerieux Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.7.5 BioMerieux Recent Development
11.8 ARKRAY
11.8.1 ARKRAY Company Details
11.8.2 ARKRAY Business Overview
11.8.3 ARKRAY Point of Care Blood Testing Product Introduction
11.8.4 ARKRAY Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.8.5 ARKRAY Recent Development
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Details
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Point of Care Blood Testing Product Introduction
11.9.4 Bio-Rad Laboratories Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.9.5 Bio-Rad Laboratories Recent Development
11.10 Nova Biomedical
11.10.1 Nova Biomedical Company Details
11.10.2 Nova Biomedical Business Overview
11.10.3 Nova Biomedical Point of Care Blood Testing Product Introduction
11.10.4 Nova Biomedical Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.10.5 Nova Biomedical Recent Development
11.11 QuidelOrtho
11.11.1 QuidelOrtho Company Details
11.11.2 QuidelOrtho Business Overview
11.11.3 QuidelOrtho Point of Care Blood Testing Product Introduction
11.11.4 QuidelOrtho Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.11.5 QuidelOrtho Recent Development
11.12 Accriva
11.12.1 Accriva Company Details
11.12.2 Accriva Business Overview
11.12.3 Accriva Point of Care Blood Testing Product Introduction
11.12.4 Accriva Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.12.5 Accriva Recent Development
11.13 OraSure Technologies
11.13.1 OraSure Technologies Company Details
11.13.2 OraSure Technologies Business Overview
11.13.3 OraSure Technologies Point of Care Blood Testing Product Introduction
11.13.4 OraSure Technologies Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.13.5 OraSure Technologies Recent Development
11.14 Helena Laboratories
11.14.1 Helena Laboratories Company Details
11.14.2 Helena Laboratories Business Overview
11.14.3 Helena Laboratories Point of Care Blood Testing Product Introduction
11.14.4 Helena Laboratories Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.14.5 Helena Laboratories Recent Development
11.15 Phamatech
11.15.1 Phamatech Company Details
11.15.2 Phamatech Business Overview
11.15.3 Phamatech Point of Care Blood Testing Product Introduction
11.15.4 Phamatech Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.15.5 Phamatech Recent Development
11.16 Chembio Diagnostics
11.16.1 Chembio Diagnostics Company Details
11.16.2 Chembio Diagnostics Business Overview
11.16.3 Chembio Diagnostics Point of Care Blood Testing Product Introduction
11.16.4 Chembio Diagnostics Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.16.5 Chembio Diagnostics Recent Development
11.17 Trinity Biotech
11.17.1 Trinity Biotech Company Details
11.17.2 Trinity Biotech Business Overview
11.17.3 Trinity Biotech Point of Care Blood Testing Product Introduction
11.17.4 Trinity Biotech Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.17.5 Trinity Biotech Recent Development
11.18 Wuhan Easy Diagnosis
11.18.1 Wuhan Easy Diagnosis Company Details
11.18.2 Wuhan Easy Diagnosis Business Overview
11.18.3 Wuhan Easy Diagnosis Point of Care Blood Testing Product Introduction
11.18.4 Wuhan Easy Diagnosis Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.18.5 Wuhan Easy Diagnosis Recent Development
11.19 Intec PRODUCT
11.19.1 Intec PRODUCT Company Details
11.19.2 Intec PRODUCT Business Overview
11.19.3 Intec PRODUCT Point of Care Blood Testing Product Introduction
11.19.4 Intec PRODUCT Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.19.5 Intec PRODUCT Recent Development
11.20 Sinocare
11.20.1 Sinocare Company Details
11.20.2 Sinocare Business Overview
11.20.3 Sinocare Point of Care Blood Testing Product Introduction
11.20.4 Sinocare Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.20.5 Sinocare Recent Development
11.21 Wondfo
11.21.1 Wondfo Company Details
11.21.2 Wondfo Business Overview
11.21.3 Wondfo Point of Care Blood Testing Product Introduction
11.21.4 Wondfo Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.21.5 Wondfo Recent Development
11.22 Getein Biotech
11.22.1 Getein Biotech Company Details
11.22.2 Getein Biotech Business Overview
11.22.3 Getein Biotech Point of Care Blood Testing Product Introduction
11.22.4 Getein Biotech Revenue in Point of Care Blood Testing Product Business (2021–2026)
11.22.5 Getein Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Point of Care Blood Testing Product Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Consumables
Table 3. Key Players of Devices
Table 4. Global Point of Care Blood Testing Product Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Point of Care Blood Testing Product Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Point of Care Blood Testing Product Market Size by Region (US$ Million), 2021–2026
Table 7. Global Point of Care Blood Testing Product Market Share by Region (2021–2026)
Table 8. Global Point of Care Blood Testing Product Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Point of Care Blood Testing Product Market Share by Region (2027–2032)
Table 10. Point of Care Blood Testing Product Market Trends
Table 11. Point of Care Blood Testing Product Market Drivers
Table 12. Point of Care Blood Testing Product Market Challenges
Table 13. Point of Care Blood Testing Product Market Restraints
Table 14. Global Point of Care Blood Testing Product Revenue by Players (US$ Million), 2021–2026
Table 15. Global Point of Care Blood Testing Product Market Share by Players (2021–2026)
Table 16. Global Top Point of Care Blood Testing Product Players by Tier (Tier 1, Tier 2, and Tier 3), based on Point of Care Blood Testing Product Revenue, 2025
Table 17. Ranking of Global Top Point of Care Blood Testing Product Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Point of Care Blood Testing Product Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Point of Care Blood Testing Product, Headquarters and Area Served
Table 20. Global Key Players of Point of Care Blood Testing Product, Products and Applications
Table 21. Global Key Players of Point of Care Blood Testing Product, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Point of Care Blood Testing Product Market Size by Type (US$ Million), 2021–2026
Table 24. Global Point of Care Blood Testing Product Revenue Market Share by Type (2021–2026)
Table 25. Global Point of Care Blood Testing Product Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Point of Care Blood Testing Product Revenue Market Share by Type (2027–2032)
Table 27. Global Point of Care Blood Testing Product Market Size by Application (US$ Million), 2021–2026
Table 28. Global Point of Care Blood Testing Product Revenue Market Share by Application (2021–2026)
Table 29. Global Point of Care Blood Testing Product Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Point of Care Blood Testing Product Revenue Market Share by Application (2027–2032)
Table 31. North America Point of Care Blood Testing Product Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Point of Care Blood Testing Product Market Size by Country (US$ Million), 2021–2026
Table 33. North America Point of Care Blood Testing Product Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Point of Care Blood Testing Product Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Point of Care Blood Testing Product Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Point of Care Blood Testing Product Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Point of Care Blood Testing Product Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Point of Care Blood Testing Product Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Point of Care Blood Testing Product Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Point of Care Blood Testing Product Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Point of Care Blood Testing Product Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Point of Care Blood Testing Product Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Point of Care Blood Testing Product Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Point of Care Blood Testing Product Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Point of Care Blood Testing Product Market Size by Country (US$ Million), 2027–2032
Table 46. Roche Company Details
Table 47. Roche Business Overview
Table 48. Roche Point of Care Blood Testing Product Product
Table 49. Roche Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 50. Roche Recent Development
Table 51. Abbott Company Details
Table 52. Abbott Business Overview
Table 53. Abbott Point of Care Blood Testing Product Product
Table 54. Abbott Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 55. Abbott Recent Development
Table 56. LifeScan Company Details
Table 57. LifeScan Business Overview
Table 58. LifeScan Point of Care Blood Testing Product Product
Table 59. LifeScan Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 60. LifeScan Recent Development
Table 61. Siemens Healthineers Company Details
Table 62. Siemens Healthineers Business Overview
Table 63. Siemens Healthineers Point of Care Blood Testing Product Product
Table 64. Siemens Healthineers Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 65. Siemens Healthineers Recent Development
Table 66. Danaher Company Details
Table 67. Danaher Business Overview
Table 68. Danaher Point of Care Blood Testing Product Product
Table 69. Danaher Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 70. Danaher Recent Development
Table 71. Ascensia Company Details
Table 72. Ascensia Business Overview
Table 73. Ascensia Point of Care Blood Testing Product Product
Table 74. Ascensia Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 75. Ascensia Recent Development
Table 76. BioMerieux Company Details
Table 77. BioMerieux Business Overview
Table 78. BioMerieux Point of Care Blood Testing Product Product
Table 79. BioMerieux Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 80. BioMerieux Recent Development
Table 81. ARKRAY Company Details
Table 82. ARKRAY Business Overview
Table 83. ARKRAY Point of Care Blood Testing Product Product
Table 84. ARKRAY Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 85. ARKRAY Recent Development
Table 86. Bio-Rad Laboratories Company Details
Table 87. Bio-Rad Laboratories Business Overview
Table 88. Bio-Rad Laboratories Point of Care Blood Testing Product Product
Table 89. Bio-Rad Laboratories Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 90. Bio-Rad Laboratories Recent Development
Table 91. Nova Biomedical Company Details
Table 92. Nova Biomedical Business Overview
Table 93. Nova Biomedical Point of Care Blood Testing Product Product
Table 94. Nova Biomedical Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 95. Nova Biomedical Recent Development
Table 96. QuidelOrtho Company Details
Table 97. QuidelOrtho Business Overview
Table 98. QuidelOrtho Point of Care Blood Testing Product Product
Table 99. QuidelOrtho Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 100. QuidelOrtho Recent Development
Table 101. Accriva Company Details
Table 102. Accriva Business Overview
Table 103. Accriva Point of Care Blood Testing Product Product
Table 104. Accriva Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 105. Accriva Recent Development
Table 106. OraSure Technologies Company Details
Table 107. OraSure Technologies Business Overview
Table 108. OraSure Technologies Point of Care Blood Testing Product Product
Table 109. OraSure Technologies Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 110. OraSure Technologies Recent Development
Table 111. Helena Laboratories Company Details
Table 112. Helena Laboratories Business Overview
Table 113. Helena Laboratories Point of Care Blood Testing Product Product
Table 114. Helena Laboratories Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 115. Helena Laboratories Recent Development
Table 116. Phamatech Company Details
Table 117. Phamatech Business Overview
Table 118. Phamatech Point of Care Blood Testing Product Product
Table 119. Phamatech Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 120. Phamatech Recent Development
Table 121. Chembio Diagnostics Company Details
Table 122. Chembio Diagnostics Business Overview
Table 123. Chembio Diagnostics Point of Care Blood Testing Product Product
Table 124. Chembio Diagnostics Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 125. Chembio Diagnostics Recent Development
Table 126. Trinity Biotech Company Details
Table 127. Trinity Biotech Business Overview
Table 128. Trinity Biotech Point of Care Blood Testing Product Product
Table 129. Trinity Biotech Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 130. Trinity Biotech Recent Development
Table 131. Wuhan Easy Diagnosis Company Details
Table 132. Wuhan Easy Diagnosis Business Overview
Table 133. Wuhan Easy Diagnosis Point of Care Blood Testing Product Product
Table 134. Wuhan Easy Diagnosis Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 135. Wuhan Easy Diagnosis Recent Development
Table 136. Intec PRODUCT Company Details
Table 137. Intec PRODUCT Business Overview
Table 138. Intec PRODUCT Point of Care Blood Testing Product Product
Table 139. Intec PRODUCT Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 140. Intec PRODUCT Recent Development
Table 141. Sinocare Company Details
Table 142. Sinocare Business Overview
Table 143. Sinocare Point of Care Blood Testing Product Product
Table 144. Sinocare Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 145. Sinocare Recent Development
Table 146. Wondfo Company Details
Table 147. Wondfo Business Overview
Table 148. Wondfo Point of Care Blood Testing Product Product
Table 149. Wondfo Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 150. Wondfo Recent Development
Table 151. Getein Biotech Company Details
Table 152. Getein Biotech Business Overview
Table 153. Getein Biotech Point of Care Blood Testing Product Product
Table 154. Getein Biotech Revenue in Point of Care Blood Testing Product Business (US$ Million), 2021–2026
Table 155. Getein Biotech Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
Table 159. Authors List of This Report
List of Figures
Figure 1. Point of Care Blood Testing Product Picture
Figure 2. Global Point of Care Blood Testing Product Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Point of Care Blood Testing Product Market Share by Type: 2025 vs 2032
Figure 4. Consumables Features
Figure 5. Devices Features
Figure 6. Global Point of Care Blood Testing Product Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Point of Care Blood Testing Product Market Share by Application: 2025 vs 2032
Figure 8. Hospital & Clinic Case Studies
Figure 9. Laboratory Case Studies
Figure 10. Household Case Studies
Figure 11. Other Case Studies
Figure 12. Point of Care Blood Testing Product Report Years Considered
Figure 13. Global Point of Care Blood Testing Product Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Point of Care Blood Testing Product Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Point of Care Blood Testing Product Market Share by Region: 2025 vs 2032
Figure 16. Global Point of Care Blood Testing Product Market Share by Players in 2025
Figure 17. Global Point of Care Blood Testing Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Point of Care Blood Testing Product Revenue in 2025
Figure 19. North America Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Point of Care Blood Testing Product Market Share by Country (2021–2032)
Figure 21. United States Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Point of Care Blood Testing Product Market Share by Country (2021–2032)
Figure 25. Germany Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Point of Care Blood Testing Product Market Share by Region (2021–2032)
Figure 33. China Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Point of Care Blood Testing Product Market Share by Country (2021–2032)
Figure 41. Mexico Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Point of Care Blood Testing Product Market Share by Country (2021–2032)
Figure 45. Israel Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Point of Care Blood Testing Product Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Roche Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 49. Abbott Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 50. LifeScan Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 51. Siemens Healthineers Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 52. Danaher Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 53. Ascensia Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 54. BioMerieux Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 55. ARKRAY Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 56. Bio-Rad Laboratories Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 57. Nova Biomedical Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 58. QuidelOrtho Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 59. Accriva Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 60. OraSure Technologies Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 61. Helena Laboratories Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 62. Phamatech Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 63. Chembio Diagnostics Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 64. Trinity Biotech Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 65. Wuhan Easy Diagnosis Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 66. Intec PRODUCT Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 67. Sinocare Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 68. Wondfo Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 69. Getein Biotech Revenue Growth Rate in Point of Care Blood Testing Product Business (2021–2026)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed